2024年中国消费健康行业发展报告_154页_4mb

The Chinese government elevates the "Healthy China" objective to a national strategy, supported by policies like the "Healthy China 2030" initiative and regulatory frameworks. The industry encompasses four main sectors: OTC drugs, health supplements, personal care, and medical nutrition products, with a compound annual growth rate of 7%, projected to reach 16 trillion CNY by 2030. Demographic shifts (population aging and rising incomes) drive demand, with young consumers increasingly prioritizing personal care and women's health. Digital tools, personalized products, and innovative marketing models are key trends. However, the industry faces challenges including regulatory hurdles, supply chain inefficiencies, and limited pediatric product development. Enterprises recommend expanding OTC scope, encouraging localization, and integrating traditional Chinese medicine to foster sustainable growth. The government's focus on ESG and cross-border collaboration aims to create a robust ecosystem for long-term industry development.